Artisan Partners’s Ascendis Pharma A/S ASND Stock Holding History

Artisan Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739M	Buy	3,230,188 +4,303	+0.1%	+$965K	1.19%	23
2025 Q4	$688M	Sell	3,225,885 -494,995	-13%	-$102M	1.03%	23
2025 Q3	$740M	Sell	3,720,880 -269,544	-7%	-$50.3M	1.05%	24
2025 Q2	$689M	Sell	3,990,424 -266,203	-6%	-$43.4M	1.01%	29
2025 Q1	$663M	Sell	4,256,627 -193,793	-4%	-$27.7M	1.07%	23
2024 Q4	$613M	Buy	4,450,420 +39,309	+0.9%	+$5.17M	0.92%	27
2024 Q3	$659M	Buy	4,411,111 +116,082	+3%	+$15.7M	0.98%	26
2024 Q2	$586M	Sell	4,295,029 -1,376,905	-24%	-$187M	0.88%	35
2024 Q1	$857M	Sell	5,671,934 -77,293	-1%	-$11M	1.24%	24
2023 Q4	$724M	Sell	5,749,227 -246,181	-4%	-$24.5M	1.11%	24
2023 Q3	$561M	Sell	5,995,408 -227,043	-4%	-$21.2M	0.95%	28
2023 Q2	$555M	Sell	6,222,451 -622,290	-9%	-$54.2M	0.89%	34
2023 Q1	$734M	Sell	6,844,741 -75,615	-1%	-$8.65M	1.21%	21
2022 Q4	$845M	Sell	6,920,356 -229,137	-3%	-$26.6M	1.49%	13
2022 Q3	$738M	Sell	7,149,493 -323,593	-4%	-$30.7M	1.3%	17
2022 Q2	$695M	Sell	7,473,086 -739,852	-9%	-$69.7M	1.17%	20
2022 Q1	$964M	Buy	8,212,938 +272,504	+3%	+$31.6M	1.27%	17
2021 Q4	$1.07B	Buy	7,940,434 +155,574	+2%	+$23.1M	1.27%	16
2021 Q3	$1.24B	Buy	7,784,860 +1,355,453	+21%	+$186M	1.51%	8
2021 Q2	$846M	Buy	6,429,407 +382,517	+6%	+$51M	1.01%	29
2021 Q1	$779M	Buy	6,046,890 +279,363	+5%	+$42.5M	0.99%	31
2020 Q4	$962M	Buy	5,767,527 +152,310	+3%	+$25.2M	1.17%	14
2020 Q3	$867M	Buy	5,615,217 +1,583,713	+39%	+$228M	1.22%	16
2020 Q2	$596M	Buy	4,031,504 +1,472,148	+58%	+$202M	0.96%	29
2020 Q1	$288M	Buy	2,559,356 +402,960	+19%	+$52.4M	0.62%	52
2019 Q4	$300M	Buy	2,156,396 +16,731	+0.8%	+$1.86M	0.53%	58
2019 Q3	$206M	Buy	2,139,665 +546,398	+34%	+$61M	0.39%	67
2019 Q2	$183M	Buy	1,593,267 +462,160	+41%	+$55.3M	0.34%	73
2019 Q1	$133M	Buy	1,131,107 +764,160	+208%	+$66.9M	0.26%	79
2018 Q4	$23M	Buy	366,947 +135,275	+58%	+$8.5M	0.05%	209
2018 Q3	$16.4M	Buy	231,672 +144,561	+166%	+$9.95M	0.03%	220
2018 Q2	$5.79M	Buy	+87,111	New	+$5.73M	0.01%	245

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artisan Partners's ASND Position: Q1 2026 in Review

Artisan Partners increased its Ascendis Pharma A/S (ASND) stake by 0.13% in Q1 2026, buying an estimated $965K and bringing the position to 3,230,188 shares worth $739M. The position accounts for 1.19% of the portfolio, ranked #23.

Artisan Partners first reported a position in ASND in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.24B in Q3 2021. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Artisan Partners held 3,230,188 shares of Ascendis Pharma A/S worth $739M as of Q1 2026.
Artisan Partners bought 4,303 Ascendis Pharma A/S shares in Q1 2026, an estimated $965K.
Ascendis Pharma A/S made up 1.19% of Artisan Partners's portfolio in Q1 2026, its #23 holding.
Artisan Partners first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 32 quarters since.
Artisan Partners's Ascendis Pharma A/S position peaked at $1.24B in Q3 2021.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Artisan Partners's 13F filing for Q1 2026, filed 13 May 2026.